For instance, it has been observed that the presence of different forms of TGF-β1 propeptide, latency-associated peptide (LAP), and mature TGF-β1 in plasma EXs reflects the effects of chemotherapy and might be used as an indicator of AML relapse (117). The gene discussed is TGFB1; the disease is acute myeloid leukemia.